Kadry Elsaeed

Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt

Heba Omar, Tamer Elbaz, Mohamed El‐Kassas et al. · Alimentary Pharmacology & Therapeutics · 2017 · 126 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience

Aisha Elsharkawy, Maissa El Raziky, Wafaa Elakel et al. · Journal of Hepatology · 2017 · 76 citations

Medicine, Health Policy, Infectious Diseases +17

Paraoxonase‐1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients

Saeed Abdelwhab Saeed, Magdy ElSharkawy, Kadry Elsaeed et al. · Hemodialysis International · 2008 · 35 citations

Medicine, Biochemistry, Nephrology +11

Egyptian recommendations for management of Helicobacter pylori infection: 2018 report

Mohamed Alboraie, Walied Elhossary, Osama Aboelfotoh Aly et al. · Arab Journal of Gastroenterology · 2019 · 34 citations

Pharmacy, Infectious Diseases, Microbiology +7

An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens

Mohamed El‐Kassas, Mohamed Alboraie, Dalia Omran et al. · Expert Review of Gastroenterology & Hepatology · 2018 · 32 citations

Pharmacy, Infectious Diseases, Hepatitis Pharmacotherapy +14